Skip to content

Investigation of clinical outcomes of patients treated with short duration dual antiplatelet therapy after implantation of biodREsorbable-polymer drug-eluting stent

Investigation of clinical outcomes of patients treated with short duration dual antiplatelet therapy after implantation of biodREsorbable-polymer drug-eluting stent: A multicenter, prospective registry from IWAte medical university affiliated hospitals - REIWA registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037321
Enrollment
1200
Registered
2019-07-10
Start date
2019-07-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

None listed

Sponsors

Division of Cardiology, Department of Internal Medicine, Iwate Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients with successful BP-DES implantation as well as no major adverse events (death, new onset AMI, stroke, major bleeding) during hospitalization 2) Patients who can continue DAPT of aspirin and P2Y12 receptor antagonist 3) Patients with completed informed consent

Exclusion criteria

Exclusion criteria: 1) patients requiring oral anticoagulant 2) patients with previous history of stent thrombosis 3)patients treated with any stents except BP-DES 4) patients known to have intolerance of P2Y12 receptor antagonist 5) patients requiring other antiplatelet agents except aspirin and P2Y12 inhibitor 6) patients who have cancer with life expectancy shorter than 2 years 7) pregnant or antcipated pregnant woman 8) patients implanted bioresorbable scaffold within 3 years

Design outcomes

Primary

MeasureTime frame
Composite endpointof cardiovascular death, stroke, stent thrombosis, clinically significant bleeding

Secondary

MeasureTime frame
Cardiovascular death/ MI/ stroke/ definite ST at 12 months Major bleeding (TIMI Major/ Minor) at 12 months

Countries

Japan

Contacts

Public ContactYumiko Okuyama

Iwate Medical University Hospital Division of Cardiology, Department of Internal Medicine

yokuyama@iwate-med.ac.jp+81-19-613-7111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026